| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Interest income: |
| Interest income on loans | 165.7 | 151.3 | 140.6 | 131.9 | 127.4 | 125.8 | 123.5 | 122.8 |
| Interest income on investments | 16.2 | 14.4 | 12.5 | 10.8 | 10.1 | 9.4 | 9.0 | 9.1 |
| | 194.9 | 172.9 | 156.9 | 145.4 | 139.4 | 136.6 | 133.9 | 133.3 |
| Interest on deposits | 91.3 | 63.0 | 41.8 | 29.4 | 26.0 | 27.3 | 29.8 | 34.0 |
| Total interest expense | 111.5 | 82.0 | 59.8 | 46.5 | 43.5 | 44.9 | 47.3 | 51.4 |
| Net interest income | 83.4 | 90.9 | 97.1 | 98.9 | 95.9 | 91.8 | 86.6 | 81.9 |
| Provision for loan losses | | 9.4 | | | | 0.8 | | |
| Net interest income after provision for loan losses | 74.0 | 81.5 | 96.3 | 98.1 | 95.1 | 91.0 | 86.6 | 81.9 |
| Other non-interest income | 21.4 | 19.9 | 21.3 | 23.1 | 26.6 | 31.3 | 32.8 | 37.8 |
| Total non-interest income | 21.4 | 19.9 | 21.3 | 23.1 | 26.6 | 31.3 | 32.8 | 37.8 |
| Non-interest expenses | 76.1 | 75.4 | 73.3 | 71.7 | 68.2 | 65.3 | 61.8 | 59.4 |
| Pre-tax income before non-recurring items | 14.6 | 21.8 | 40.1 | 50.3 | 55.1 | 59.8 | 59.1 | 56.2 |
| Non-recurring items | | | | | | | 2.5 | |
| Pre-tax income | 14.6 | 21.8 | 40.1 | 47.7 | 52.6 | 57.3 | 56.6 | 56.2 |
| Income taxes | -1.1 | 0.4 | 4.6 | 6.1 | 7.3 | 8.4 | 8.5 | 9.5 |
| Tax rate | | 2.0% | 11.4% | 12.7% | 13.9% | 14.7% | 15.0% | 16.9% |
| Net income | 15.7 | 21.3 | 35.5 | 41.7 | 45.3 | 48.9 | 48.1 | 46.7 |
| Net margin | 16.4% | 21.0% | 30.2% | 34.4% | 37.2% | 40.0% | 40.3% | 39.0% |
| |
| Basic EPS | $1.70 | $2.27 | $3.70 | $4.30 | $4.62 | $4.94 | $4.85 | $4.72 |
| Diluted EPS | $1.69 | $2.26 | $3.68 | $4.27 | $4.59 | $4.91 | $4.82 | $4.70 |
| |
| Shares outstanding (basic) | 9.2 | 9.4 | 9.6 | 9.7 | 9.8 | 9.9 | 9.9 | 9.9 |
| Shares outstanding (diluted) | 9.3 | 9.5 | 9.7 | 9.8 | 9.9 | 10.0 | 10.0 | 9.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |